# Hospice Care Provider Model

See how referrals, patient care, clinical staffing, and reimbursement shape a hospice business.

- Canonical: https://finamodel.com/templates/hospice
- Excel download: https://finamodel.com/templates/hospice.xlsx
- Category: Healthcare
- Model type: Operating model
- Difficulty: Intermediate
- Audiences: Investors & analysts, Founders & operators, Hospice owners and operators, Healthcare services investors, Search-fund and PE buyers, Lenders and analysts
- Tags: hospice, medicare-hospice-cap, medicare-reimbursement, healthcare-services, dcf

## Overview

This model helps you plan a hospice provider supporting patients and families through end-of-life care. It connects referrals, patient census, length of stay, and care needs to the nurses, clinicians, facilities, and support services required to deliver compassionate care.

Use it to assess an acquisition, new market, or growth plan. Test referral demand, staffing, reimbursement, and care mix to understand the effect on finances and business value.

## What's included

- Admissions & census inputs: Year-1 admissions, admission growth rate, average length of stay (ALOS) and its annual increase
- RHC two-tier per diem: Tier 1 and Tier 2 rates, the day-61 tier threshold, and the hospice payment rate update
- Other levels of care: CHC, IRC and GIP per-diem rates and day shares
- Payer mix & the Medicare hospice aggregate cap: Medicare mix %, cap amount per beneficiary and its annual update
- Interdisciplinary team staffing: five role ratios (RN, aide, social worker, chaplain, volunteer coordinator) and wages, benefits load, wage growth
- Medical director, physician & bereavement: fixed medical director fee, physician visits per ADC and fee per visit, CMS-required bereavement cost per admission
- Drugs, DME & supplies: cost per patient-day
- Overhead staffing & capex: back-office ratio and wage, QA and corporate FTE and wages, field-device capex per net-new FTE, EMR platform capex %, useful life, base PP&E and clinical FTE
- Cost structure: accreditation fee, marketing %, G&A %, liability insurance %
- Tax: corporate tax rate on EBIT
- Working capital: Medicare billing lag (days), base claims receivable
- Valuation: WACC, terminal growth, net debt, shares outstanding
- Operations sheet: admissions/ALOS/patient-days/ADC roll-forward, the level-of-care mix and RHC two-tier build, per-diem rates by level, the Medicare aggregate cap test, IDT staffing and cost, medical/bereavement, drugs/DME/supplies, capex and PP&E, and the Medicare claims-receivable working-capital build
- Revenue sheet: gross and net Medicare revenue, non-Medicare revenue, total net patient revenue, and cap-mechanic KPIs (revenue per beneficiary, cap overage $ and % of revenue, blended per diem, ALOS, Tier 2 share)
- P&L sheet: revenue to net income with bottom-up cost of hospice care, the opex stack, margins, identity check
- FCF sheet: NOPAT, depreciation add-back, capex, the claims-receivable balance and its change, unlevered FCF, discount factor, PV
- Valuation sheet: sum of PV, terminal value, enterprise value, net debt, equity value, value per share, implied EV/EBITDA (Y7)
- Dashboard with admissions, ALOS, aggregate cap overage (Y1 and Y7), revenue, EBITDA margin, net income, enterprise value, value per share, a seven-year summary, trend grid and Revenue-to-Net-Income waterfall

## Inside a Hospice Financial Model: Cap, Staffing, and Valuation

This hospice financial model projects a Medicare-certified provider over seven years, linking referrals to patient days, per-diem revenue, staffing, and valuation. It makes the Medicare aggregate cap a visible constraint and derives care costs from census.

The page explains the model's documented drivers, calculation flow, outputs, and practical use for evaluating acquisitions or growth plans.

### Admissions, Length of Stay, and Level-of-Care Mix

The model begins with annual referral admissions, which grow from a base year at a set rate, and an average length of stay (ALOS) that rises linearly. Patient days equal admissions times ALOS, and average daily census (ADC) is patient days divided by 365.

- Those days are split across four levels of care—routine home care (RHC), continuous home care (CHC), inpatient respite care (IRC), and general inpatient care (GIP)—with RHC representing the vast majority. Each level carries its own per-diem rate, and the RHC rate is further divided into two tiers: a higher rate for days 1–60 and a lower rate for day 61 onward.

- The Tier 2 share is derived directly from ALOS, so as ALOS rises, a larger portion of RHC days prices at the lower tier. This mechanically ties the length-of-stay assumption to the blended per-diem rate, creating a natural compression in revenue per day even as individual rates inflate.

CHC, IRC, and GIP are held at small, flat day shares but carry materially higher per-diem rates, adding a premium to the overall blended rate.

### The Medicare Aggregate Cap and Net Revenue

A defining feature of this hospice financial model is the Medicare aggregate cap, a regulatory clawback that limits total Medicare payments per beneficiary. The model calculates an aggregate cap dollar amount by multiplying a cap per beneficiary (inflated annually) by the number of beneficiaries served, approximated as Medicare mix percentage times admissions.

- Medicare revenue gross is then tested against this cap each year, and any excess is recorded as a contra-revenue overage that reduces net patient revenue. The overage is zero in early years when revenue per beneficiary is below the cap, but as ALOS lengthens, average revenue per beneficiary climbs.

- Eventually, it exceeds the inflating cap, triggering an overage that grows in later years. This mechanic directly links case-mix to profitability and highlights a genuine regulatory constraint.

Non-Medicare revenue is added to net Medicare revenue to arrive at total net patient revenue, which feeds the P&L and valuation.

### Bottom-Up Staffing and Cost of Care

Instead of using a percentage of revenue, the model builds the interdisciplinary team (IDT) from average daily census. Five roles—RN case managers, hospice aides, social workers, chaplains, and a volunteer coordinator—scale at specific caseload ratios per ADC.

- Each role carries a wage that escalates annually and a benefits load. Layered on top are a fixed medical director fee, per-visit physician fees, and a CMS-required bereavement program cost per admission.

- Drugs, durable medical equipment, and medical supplies are modeled as a cost per patient day because they are not separately billable under the Medicare Hospice Benefit. Together, IDT labor, medical and bereavement costs, and supplies form the cost of hospice care.

This bottom-up approach ensures costs grow with patient volume and reflect the true unit economics of delivering hospice services, rather than relying on a margin assumption.

### Outputs, Valuation, and Practical Use

The model flows through to a P&L, unlevered free cash flow, and a discounted cash flow valuation. It outputs key metrics on a dashboard, including admissions, ALOS, cap overage, revenue, EBITDA margin, net income, enterprise value, and value per share.

- The P&L starts with net patient revenue, subtracts the bottom-up cost of hospice care, then overhead, marketing, G&A, and insurance to reach EBITDA. Depreciation and taxes lead to net income.

- Free cash flow is NOPAT plus depreciation minus capex and changes in working capital, where working capital is the Medicare claims receivable based on a billing lag. The DCF discounts free cash flow at WACC and adds a Gordon-growth terminal value to derive enterprise value, then adjusts for net debt to get equity value.

This structure allows users to test referral demand, staffing, reimbursement, and care mix, and to assess acquisitions, new markets, or growth plans by seeing how regulatory and operational drivers affect financial outcomes and business value.

## A real regulatory clawback, not a cosmetic line

The Medicare Hospice Aggregate Cap tests total Medicare payments against a per-beneficiary statutory cap every year - cap overage = MAX(0, Medicare revenue - cap amount x beneficiaries served) - and recognizes any excess as a contra-revenue recoupment reducing net patient revenue in the year it is determined, exactly as CMS-audited hospices accrue it. The overage is genuinely $0 in Years 1-4, then turns positive at $194k in Year 5 and grows to $7.13M by Year 7, reversing several years of prior margin expansion.

## The RHC tier mechanic and the aggregate cap are formula-linked, not two unrelated assumptions

Tier 2 share of routine home care days is derived directly from average length of stay (MAX(0, (ALOS-60)/ALOS)), not set as an independent trend. As ALOS rises from 75 to 165 days over the horizon - a deliberate shift from short, hospital-referred cancer admissions to long, SNF- and dementia-referred stays - Tier 2 share climbs mechanically from 20.0% to 63.6%, and that same lengthening stay is what pushes average Medicare revenue per beneficiary past the inflating cap. One case-mix story drives both mechanics.

## Interdisciplinary staffing and hospice-specific costs are bottom-up flows

RN case managers, hospice aides, social workers, chaplains and a volunteer coordinator (required by CMS to deliver at least 5% of patient care hours) all scale off Average Daily Census at real caseload ratios, never a percent-of-revenue assumption. The CMS-required bereavement program and per-patient-day drugs/DME/supplies costs - not separately billable under the Medicare Hospice Benefit - are modeled as genuine unit costs, the same posture the library uses for home health's visit-based clinical labor and pawn shop's forfeiture-based COGS.

## Workbook structure

### Cover

Workbook overview, sheet legend, units, and tab-colour key.

- Title and scope framing (Medicare-certified hospice, not a hospital or home health agency)
- Sheet-by-sheet purpose summary
- Units and tab-colour legend

### Dashboard

Headline KPIs, a seven-year summary, a trend grid, and an earnings waterfall.

- KPI cards for Year-1 admissions, Year-7 ALOS, and the aggregate cap overage (Year 1 and Year 7)
- Revenue, EBITDA margin, net income, enterprise value and value per share
- Seven-year operating summary that feeds every chart
- Trend grid contrasting ADC, revenue, EBITDA margin, Tier 2 RHC share, cap overage and net income, plus a Revenue-to-Net-Income waterfall

### Assumptions

Every driver in one sheet: admissions, the RHC two-tier build, other levels of care, the aggregate cap, staffing, costs, tax, working capital, valuation.

- Year-1 admissions, admission growth rate, average length of stay and its annual increase
- RHC Tier 1 and Tier 2 per-diem rates, the day-61 tier threshold, hospice payment rate update
- CHC, IRC and GIP per-diem rates and day shares
- Medicare mix %, cap amount per beneficiary and its annual update
- Five IDT role ratios and wages, benefits load, wage growth
- Medical director fee, physician visits per ADC and fee per visit, bereavement cost per admission
- Drugs/DME/supplies cost per patient-day
- Back-office ratio and wage, QA and corporate FTE and wages, field-device and EMR-platform capex, useful life, base PP&E and clinical FTE
- Accreditation fee, marketing %, G&A %, liability insurance %
- Corporate tax rate
- Billing lag (days) and base claims receivable
- WACC, terminal growth, net debt, shares

### Operations

Admissions/ALOS/patient-days/ADC roll-forward, the level-of-care mix and RHC two-tier build, the Medicare aggregate cap test, and bottom-up staffing and cost.

- Referral admissions grow annually; average length of stay rises and multiplies into patient days and Average Daily Census
- Patient days split across RHC (two-tier), CHC, IRC and GIP; Tier 2 RHC share derived mechanically from ALOS
- Per-diem rates by level of care, plus a day-weighted blended per-diem KPI
- Medicare vs. non-Medicare revenue split; beneficiaries served, the aggregate cap, and the resulting cap overage
- Interdisciplinary team FTE and cost by role; medical director, physician and bereavement costs; drugs/DME/supplies
- Overhead staffing, capex and PP&E; the Medicare claims-receivable working-capital build

### Revenue

Net patient service revenue and the cap mechanic isolated as explicit KPIs.

- Gross Medicare revenue, less the aggregate cap overage, equals net Medicare revenue
- Non-Medicare revenue and total net patient revenue
- Revenue per beneficiary, cap per beneficiary, cap overage $ and % of revenue, blended per diem, ALOS, Tier 2 share

### P&L

Revenue to net income with bottom-up cost of hospice care as a derived flow.

- Cost of hospice care = IDT labor + medical/bereavement + drugs/DME/supplies, never a percent-of-revenue assumption
- Gross profit and gross margin %
- Back-office, compliance/QA and corporate labour, accreditation fee, marketing, G&A and liability insurance to EBITDA
- Depreciation to EBIT, corporate tax, net income
- Margins, ALOS, Tier 2 share, cap overage and blended per diem KPIs, and an identity check that resolves to zero

### FCF

Unlevered free cash flow from EBIT to a discounted present value.

- EBIT less unlevered tax equals NOPAT
- Add back depreciation
- Less field-device and EMR-platform capex
- Less the change in the Medicare claims receivable
- Unlevered FCF, discount factor and PV

### Valuation

An unlevered DCF to enterprise value, equity value, and value per share.

- Sum of explicit PV plus the PV of a Gordon-growth terminal value built on a Year-7 run-rate that already carries the full cap overage
- Enterprise value less net debt equals equity value
- Value per share and an implied EV/EBITDA multiple read off mature-year (Year 7) earnings

## Features

- **A real regulatory clawback, not a cosmetic line:** The Medicare Hospice Aggregate Cap tests total Medicare payments against a per-beneficiary statutory cap every year - cap overage = MAX(0, Medicare revenue - cap amount x beneficiaries served) - and recognizes any excess as a contra-revenue recoupment reducing net patient revenue in the year it is determined, exactly as CMS-audited hospices accrue it. The overage is genuinely $0 in Years 1-4, then turns positive at $194k in Year 5 and grows to $7.13M by Year 7, reversing several years of prior margin expansion.
- **The RHC tier mechanic and the aggregate cap are formula-linked, not two unrelated assumptions:** Tier 2 share of routine home care days is derived directly from average length of stay (MAX(0, (ALOS-60)/ALOS)), not set as an independent trend. As ALOS rises from 75 to 165 days over the horizon - a deliberate shift from short, hospital-referred cancer admissions to long, SNF- and dementia-referred stays - Tier 2 share climbs mechanically from 20.0% to 63.6%, and that same lengthening stay is what pushes average Medicare revenue per beneficiary past the inflating cap. One case-mix story drives both mechanics.
- **Interdisciplinary staffing and hospice-specific costs are bottom-up flows:** RN case managers, hospice aides, social workers, chaplains and a volunteer coordinator (required by CMS to deliver at least 5% of patient care hours) all scale off Average Daily Census at real caseload ratios, never a percent-of-revenue assumption. The CMS-required bereavement program and per-patient-day drugs/DME/supplies costs - not separately billable under the Medicare Hospice Benefit - are modeled as genuine unit costs, the same posture the library uses for home health's visit-based clinical labor and pawn shop's forfeiture-based COGS.

## Use cases

- **Intrinsic valuation of a hospice provider:** Set the admissions and ALOS growth path, the RHC two-tier and other level-of-care rates, the aggregate cap parameters, the bottom-up IDT and hospice-specific cost stack, and a WACC, and read enterprise value, equity value, value per share and an implied EV/EBITDA multiple off mature-year (Year 7) earnings.
- **Aggregate cap and case-mix sensitivity testing:** Flex ALOS growth, the cap amount per beneficiary, the cap update rate, or the Medicare mix to see exactly how much a case-mix shift toward longer stays - or a slower one - moves the year the cap first binds, the size of the overage by Year 7, and the resulting EBITDA margin reversal.
- **Staffing and cash planning:** Flex the IDT caseload ratios, wage growth, or the billing-lag assumption to see how fast the claims receivable and staffing cost grow alongside patient volume, and whether the hospice's light capex base keeps unlevered free cash flow positive through the cap-driven margin compression.

## Frequently asked questions

### What is a hospice financial model?

A hospice financial model captures the seven-year operating economics and intrinsic value of a Medicare-certified hospice - routine home care, continuous home care, inpatient respite care and general inpatient care delivered to terminally ill patients electing the Medicare Hospice Benefit. It rolls referral admissions and average length of stay into patient days, prices those days by level of care including a two-tier routine-home-care per diem, tests Medicare revenue against the Medicare Hospice Aggregate Cap, derives the interdisciplinary care team bottom-up from Average Daily Census, and discounts an unlevered free-cash-flow stream to enterprise value, equity value and value per share.

### What is the Medicare hospice aggregate cap and why does it matter?

The Medicare Hospice Aggregate Cap is an annual, per-beneficiary regulatory limit: CMS compares a hospice's total Medicare payments in a cap year against a statutory cap-per-beneficiary amount multiplied by the number of Medicare beneficiaries it served, and if payments exceed that amount, the hospice must repay the excess. It matters because it is a real, audited clawback - not a modeling abstraction - that disproportionately affects hospices whose average length of stay runs long, since payment per beneficiary rises with days of care while the cap amount does not adjust for case mix.

### Why does the Tier 2 share of routine home care days climb from 20% to 64%?

Because it is mechanically derived from average length of stay (MAX(0, (ALOS-60)/ALOS)), not set as an independent trend. As the hospice's admission growth shifts from short, hospital-referred cancer admissions toward long, SNF- and dementia-referred stays, average length of stay rises from 75 to 165 days, and a mechanically larger share of each patient's routine-home-care days fall past the day-60 tier threshold - the same case-mix shift that separately pushes average Medicare revenue per beneficiary past the aggregate cap.

### Why does EBITDA margin expand and then reverse instead of moving in one direction?

Because two different forces dominate at different points in the horizon. Through Year 4, a fixed overhead base (compliance/QA and corporate FTE held flat) deleverages faster than interdisciplinary staffing and per-day supply costs scale, so EBITDA margin actually expands from 19.9% to 21.3%. From Year 5, the aggregate cap overage begins cutting directly into net revenue while patient volume and cost keep growing, reversing that expansion to 8.8% by Year 7 - an honest result showing the regulatory clawback outweighing operating leverage once the case mix has shifted far enough toward long-stay referrals.

## Related templates

- [Home Health Agency Model](https://finamodel.com/templates/home-health)
- [Medical Billing (RCM) Model](https://finamodel.com/templates/medical-billing)
- [Outpatient Clinic Model](https://finamodel.com/templates/outpatient-clinic)